Advances in transcatheter mitral and tricuspid therapies.

ABSTRACT: BACKGROUND:While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need. The advent of transcatheter therapies offer new treatment options to often elderly and frail patients at high risk for open surgery. We aimed at providing an updated review of fast-growing domain of transcatheter mitral and tricuspid technology. MAIN BODY:We reviewed the existing literature on mitral and tricuspid transcatheter therapies. Mitraclip is becoming an established therapy for secondary mitral regurgitation in selected patients with disproportionately severe regurgitation associated with moderate left ventricle dysfunction. Evidence is less convincing for primary mitral regurgitation. Trans

SUBMITTER: Overtchouk P 

PROVIDER: S-EPMC6945613 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature